PATENT CLAIM ANALYSIS

Application Number: 16266782
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["514", "278000"]

Abstract:
The present invention relates to compounds of formula (I): or pharmaceutically acceptable salts thereof, wherein L and R 1  to R 5  are as described herein, as well as processes for their manufacture, pharmaceutical compositions comprising them, and their use as medicaments.

Claim (Index 25):
A method for the treatment or prevention of renal conditions, liver conditions, inflammatory conditions, vascular conditions, cardiovascular conditions, fibrotic diseases, cancer and acute and chronic organ transplant rejection, which method comprises administering a therapeutically effective amount of a compound of formula (I) according to  claim 1  to a human being or animal in need thereof.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 99.0
- Lexical Diversity: 1.25
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15850826', '16057436', '15300762', '13822840', '11524978']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7960645308904439
- 35 USC 102 Novelty (BERT): 0.6094938827507398
- Combined Prediction Score: 0.7774074660764736
- Mean Citation Score: 435.21528
- Max Citation Score: 646.1227
- Similarity Product: 436.3370588824034

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test